百诚医药
(301096)
| 流通市值：48.66亿 | | | 总市值：63.96亿 |
| 流通股本：8309.00万 | | | 总股本：1.09亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 396,512,404.88 | 292,595,610.38 | 372,740,297.75 | 418,873,650.9 |
| 交易性金融资产 | 60,000,000 | 80,000,000 | 170,000,000 | 148,640,000 |
| 应收票据及应收账款 | 519,462,134.64 | 467,209,142.3 | 471,756,779.5 | 454,775,199.38 |
| 应收账款 | 519,462,134.64 | 467,209,142.3 | 471,756,779.5 | 454,775,199.38 |
| 应收款项融资 | 1,057,964.37 | 7,815,913.12 | 8,505,346.63 | 8,515,493.94 |
| 预付款项 | 35,670,983.83 | 25,171,719.95 | 54,627,741.34 | 42,786,663.48 |
| 其他应收款合计 | 2,813,396.07 | 9,763,234.07 | 2,667,051.57 | 2,924,898.87 |
| 存货 | 180,109,836.75 | 176,442,746.47 | 221,736,301.99 | 205,818,757.77 |
| 合同资产 | 435,233,548.05 | 426,977,051.19 | 438,406,783.55 | 372,495,141.51 |
| 其他流动资产 | 67,553,732.65 | 66,107,962.16 | 77,829,027.95 | 77,818,991.23 |
| 流动资产合计 | 1,698,414,001.24 | 1,552,083,379.64 | 1,818,269,330.28 | 1,732,648,797.08 |
| 非流动资产: | | | | |
| 长期应收款 | 20,595,665.91 | 20,424,923.61 | - | - |
| 长期股权投资 | 16,398,075.34 | 16,398,075.34 | 36,551,746.66 | 35,051,746.66 |
| 其他非流动金融资产 | 185,948,119.59 | 186,098,119.59 | 167,862,497.01 | 159,378,119.59 |
| 投资性房地产 | 3,400,000 | 3,400,000 | - | - |
| 固定资产 | 1,667,532,941.72 | 1,707,597,897.18 | 1,545,330,372.03 | 1,577,540,178.71 |
| 在建工程 | 72,068,097.83 | 66,668,570.74 | 222,979,028.7 | 219,385,240.18 |
| 使用权资产 | 2,460,237.92 | 2,621,046.26 | 2,790,695.22 | 2,961,764.06 |
| 无形资产 | 89,133,872.69 | 89,796,059.4 | 90,686,866.92 | 91,577,674.45 |
| 长期待摊费用 | 930,800.63 | 1,084,141.57 | 1,153,332.14 | 1,293,809.06 |
| 递延所得税资产 | 37,431,690.79 | 36,866,705.02 | 34,304,846.27 | 34,747,346.59 |
| 其他非流动资产 | 8,068,403.63 | 3,228,700.83 | 26,998,726.91 | 20,355,635.51 |
| 非流动资产合计 | 2,103,967,906.05 | 2,134,184,239.54 | 2,128,658,111.86 | 2,142,291,514.81 |
| 资产总计 | 3,802,381,907.29 | 3,686,267,619.18 | 3,946,927,442.14 | 3,874,940,311.89 |
| 流动负债: | | | | |
| 短期借款 | 518,129,648.61 | 510,612,148.66 | 728,463,642.16 | 670,357,445.89 |
| 应付票据及应付账款 | 105,320,101.5 | 130,142,698.85 | 110,361,562.91 | 119,363,133.28 |
| 其中：应付票据 | 9,483,548.32 | 11,646,497.96 | 15,581,684 | 19,026,134.38 |
| 应付账款 | 95,836,553.18 | 118,496,200.89 | 94,779,878.91 | 100,336,998.9 |
| 合同负债 | 81,937,825.05 | 76,055,784.45 | 95,539,119.98 | 91,452,664.27 |
| 应付职工薪酬 | 16,157,022.73 | 20,449,714.55 | 18,013,275.64 | 17,850,149.93 |
| 应交税费 | 2,664,125.11 | 7,063,013.33 | 7,303,035.62 | 4,983,886.85 |
| 其他应付款合计 | 2,687,085.43 | 5,224,779.24 | 3,876,408.58 | 4,426,730.55 |
| 一年内到期的非流动负债 | 179,561,599.4 | 170,363,969.2 | 66,443,596.2 | 43,436,436.23 |
| 流动负债合计 | 906,457,407.83 | 919,912,108.28 | 1,030,000,641.09 | 951,870,447 |
| 非流动负债: | | | | |
| 长期借款 | 310,007,497.24 | 189,507,027.78 | 238,670,937.99 | 238,671,083.97 |
| 租赁负债 | 2,501,584.11 | 2,337,213.44 | 2,864,288.3 | 3,099,391.74 |
| 预计负债 | 59,858,558.6 | 61,836,919.65 | 64,258,513.89 | 71,238,789.38 |
| 递延收益 | 21,779,487.27 | 23,720,580.21 | 25,661,673.15 | 27,602,766.09 |
| 非流动负债合计 | 394,147,127.22 | 277,401,741.08 | 331,455,413.33 | 340,612,031.18 |
| 负债合计 | 1,300,604,535.05 | 1,197,313,849.36 | 1,361,456,054.42 | 1,292,482,478.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 109,228,284 | 109,228,284 | 109,228,284 | 109,228,284 |
| 资本公积 | 2,106,813,173.52 | 2,106,813,173.52 | 2,106,813,173.52 | 2,106,813,173.52 |
| 减:库存股 | 49,998,224.77 | 49,998,224.77 | 49,998,224.77 | 49,998,224.77 |
| 其他综合收益 | -172,409.97 | -183,553.97 | -185,676.11 | -173,180.7 |
| 盈余公积 | 54,614,142 | 54,614,142 | 54,614,142 | 54,614,142 |
| 未分配利润 | 281,292,407.46 | 268,479,949.04 | 364,999,689.08 | 361,973,639.66 |
| 归属于母公司股东权益合计 | 2,501,777,372.24 | 2,488,953,769.82 | 2,585,471,387.72 | 2,582,457,833.71 |
| 股东权益合计 | 2,501,777,372.24 | 2,488,953,769.82 | 2,585,471,387.72 | 2,582,457,833.71 |
| 负债和股东权益合计 | 3,802,381,907.29 | 3,686,267,619.18 | 3,946,927,442.14 | 3,874,940,311.89 |
| 公告日期 | 2026-04-24 | 2026-04-24 | 2025-10-25 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |